• Latest Posts

Sanofi Offers up to €2.4Bn to Belgian Biotech to Develop Nanobodies

Merck to Pay Ablynx €15M for Getting a Second Nanobody ready for the Clinic

Merck Outsources the Development of its Nanobody for Psoriasis

What are the Best Countries to Recruit Biotech Talents in 2017?

An Antibody to reduce Hospitalizations of Children starts Phase IIb trials

UPDATE: The 5 Hottest European Biotechs in 2017 according to JP Morgan


Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie

Nanobody Phase II Results for Arthritis: Good but not good enough?

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies

When the Llama met the Lion: Antibodies Unlock Milestone Payment for Skin Disease